BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32651755)

  • 1. Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.
    McEvoy AM; Poplack S; Nickel K; Olsen MA; Ademuyiwa F; Zoberi I; Odom E; Yu J; Chang SH; Gillanders WE
    Breast Cancer Res Treat; 2020 Sep; 183(2):251-262. PubMed ID: 32651755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
    Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
    Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
    Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
    Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer.
    Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z
    Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.
    Cyr AE; Tucker N; Ademuyiwa F; Margenthaler JA; Aft RL; Eberlein TJ; Appleton CM; Zoberi I; Thomas MA; Gao F; Gillanders WE
    J Am Coll Surg; 2016 Aug; 223(2):399-407. PubMed ID: 27212005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SAVE review: sonographic analysis versus excision for axillary staging in breast cancer.
    Henry-Tillman R; Glover-Collins K; Preston M; Gallagher K; Tummel E; Robertson YV; Ochoa D; Korourian S; Westbrook K; Klimberg VS
    J Am Coll Surg; 2015 Apr; 220(4):560-7. PubMed ID: 25797740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
    Wellington J; Sanders T; Mylander C; Alden A; Harris C; Buras R; Tafra L; Liang W; Stelle L; Rosman M; Jackson RS
    Ann Surg Oncol; 2018 Aug; 25(8):2271-2278. PubMed ID: 29868976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
    Lee E; Tweed C; Mylander C; Martino L; Rosman M; Huerta N; Waite K; Tafra L; Jackson RS
    Clin Breast Cancer; 2021 Dec; 21(6):e731-e737. PubMed ID: 34006481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
    Tucker NS; Cyr AE; Ademuyiwa FO; Tabchy A; George K; Sharma PK; Jin LX; Sanati S; Aft R; Gao F; Margenthaler JA; Gillanders WE
    Ann Surg; 2016 Dec; 264(6):1098-1102. PubMed ID: 26779976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.
    Hrebinko KA; Bryce CL; Downs-Canner S; Diego EJ; Myers SP
    Cancer; 2022 Jun; 128(12):2258-2268. PubMed ID: 35389517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer patients with a negative axillary ultrasound may have clinically significant nodal metastasis.
    Keelan S; Heeney A; Downey E; Hegarty A; Roche T; Power C; Mhuircheartaigh NN; Duke D; Kerr J; Hambly N; Hill A
    Breast Cancer Res Treat; 2021 Jun; 187(2):303-310. PubMed ID: 33837870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients.
    Gipponi M; Fregatti P; Garlaschi A; Murelli F; Margarino C; Depaoli F; Baccini P; Gallo M; Friedman D
    Breast; 2016 Dec; 30():146-150. PubMed ID: 27728855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound.
    Fu F; Zhang Y; Sun J; Zhang C; Zhang D; Xie L; Chu F; Yu X; Xie Y
    Acta Radiol; 2022 Nov; 63(11):1463-1468. PubMed ID: 34719964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers.
    Lee MC; Eatrides J; Chau A; Han G; Kiluk JV; Khakpour N; Cox CE; Carter WB; Laronga C
    Ann Surg Oncol; 2011 Jan; 18(1):72-7. PubMed ID: 20585876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.
    Verry H; Lord SJ; Martin A; Gill G; Lee CK; Howard K; Wetzig N; Simes J
    Br J Cancer; 2012 Mar; 106(6):1045-52. PubMed ID: 22415293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of sentinel node biopsy in breast cancer patients with clinically negative and positive axilla and role of axillary ultrasound examination to select patients for sentinel node biopsy.
    Kuru B; Gulcelik MA; Topgul K; Ozaslan C; Dinc S; Dincer H; Bozgul M; Camlibel M; Alagol H
    J BUON; 2011; 16(3):454-9. PubMed ID: 22006749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
    Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
    JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.